Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Coca-Cola Co K (KO) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

The Coca-Cola Co KTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

The Coca-Cola Co K vs Vir Biotechnology Inc. Common Stock — how do they compare? The Coca-Cola Co K trades at $93.55 (market cap $394.89B), while Vir Biotechnology Inc. Common Stock trades at $10.41 (market cap $1.76B). The key difference: The Coca-Cola Co K is far larger — about 224.4× Vir Biotechnology Inc. Common Stock's market cap, and The Coca-Cola Co K pays a 2.31% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold The Coca-Cola Co K for 154 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

KOVIR
Market Cap
$394.89B$1.76B
Volume
14,523,0872,764,948
Sector
Consumer StaplesHealth
52-Week High
$91.99$11.78
52-Week Low
$67.08$5.12
Typical Hold Time
154 Days0 Days
Enterprise Value
$422.06B$1.32B
Dividend Yield
2.31%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Coca-Cola Co K

Coca-Cola (KO) trades at $90.11, up 0.36% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported Q2 2026 EPS of $0.97, beating estimates, and maintains robust profitability with a 28.56% net income margin. Recent news highlights institutional buying and stable demand trends ahead of Q3 earnings.

The outlook is positive, supported by consistent earnings beats, a high analyst buy rating (60.42%), and a $95.75 consensus price target. Risks include elevated valuation multiples and regional demand variability. The stock offers a reliable dividend, with a payout increase for 64 consecutive years.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KO
14% Buy86% Sell
Avg holding period · 154 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About The Coca-Cola Co K

The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.

Read more on KO →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →